Phase 1 18 trials
Phase 1
NCT01783171 Jan 2013 → Jul 2016 pancreatic adenocarcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01705340 Sep 2012 → May 2013 HER2 positive breast carcinoma , esophageal cancer , gastric cancer , gastroesophageal junction adenocarcinoma +1 National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT01480154 Nov 2011 → Feb 2020 overdue cutaneous melanoma , prostate cancer , renal cell adenocarcinoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1
NCT01344031 Apr → Jul 2011 estrogen-receptor positive breast cancer , invasive breast carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01235897 Mar 2011 → Mar 2013 cancer University of California, San Francisco
Completed
No outcome recorded
Phase 1
NCT01295632 Feb 2011 → Dec 2013 cancer of unknown primary site Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 1
NCT01263145 Jan 2011 → Oct 2012 breast carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01231919 Jan 2011 → Apr 2013 Burkitt lymphoma , CD4+/CD56+ hematodermic neoplasm , Hodgkins lymphoma , Waldenstrom macroglobulinemia +24 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01281163 Jan 2011 → Dec 2013 HER2 positive breast carcinoma , estrogen-receptor negative breast cancer , estrogen-receptor positive breast cancer , progesterone-receptor negative breast cancer +1 National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT01243762 Nov 2010 → Dec 2012 cancer Merck Sharp & Dohme LLC
Terminated
No outcome recorded
Phase 1
NCT01245205 Nov 2010 → Aug 2014 HER2 positive breast carcinoma , male breast carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01147211 Sep 2010 → Jul 2013 non-small cell lung carcinoma National Taiwan University Hospital
Unknown
No outcome recorded
Phase 1
NCT01071018 Feb 2010 → Sep 2011 cancer Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 1
NCT01021748 Nov 2009 → Nov 2012 —
Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 1
NCT00963547 Sep 2009 → Aug 2011 breast cancer Merck Sharp & Dohme LLC
Terminated
No outcome recorded
Phase 1
NCT00848718 Mar 2009 → May 2011 —
Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 1
NCT00670488 Apr 2008 → Jul 2011 cancer , metastatic neoplasm Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 1
NCT01240928 — breast cancer Vanderbilt-Ingram Cancer Center
Withdrawn
No outcome recorded
Show 8 more trials Phase 1/2 1 trial
Phase 1/2
NCT01369849 Sep 2011 → Feb 2014 chronic lymphocytic leukemia/small lymphocytic lymphoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2 29 trials
Phase 2
NCT01802320 Mar 2013 → Jun 2015 colon mucinous adenocarcinoma , colon signet ring cell adenocarcinoma , rectal signet ring cell adenocarcinoma , rectum mucinous adenocarcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01776008 Jan 2013 → May 2015 Her2-receptor negative breast cancer , estrogen-receptor positive breast cancer , female breast carcinoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 2
NCT01859182 Jan → May 2013 cholangiocarcinoma , gallbladder adenocarcinoma , gallbladder adenosquamous carcinoma National Cancer Institute (NCI)
Withdrawn
No outcome recorded
Phase 2
NCT01658943 Aug 2012 → Jun 2015 pancreatic acinar cell carcinoma , pancreatic ductal adenocarcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01604772 Jul 2012 → Oct 2013 major salivary gland carcinoma , salivary gland adenoid cystic carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01519427 Jan 2012 → May 2013 melanoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 2
NCT01481129 Dec 2011 → Jun 2013 diffuse large B-cell lymphoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01466868 Nov 2011 → Sep 2013 diffuse large B-cell lymphoma Centre Leon Berard
Terminated
No outcome recorded
Phase 2
NCT01370070 Jul 2011 → Dec 2016 nasopharyngeal carcinoma Chinese University of Hong Kong
Completed
No outcome recorded
Phase 2
NCT01248247 Jun 2011 → Nov 2020 lung cancer M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 2
NCT01349933 Apr 2011 → Oct 2013 nasopharyngeal squamous cell carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01319539 Apr 2011 → Jul 2013 HER2 positive breast carcinoma , estrogen-receptor positive breast cancer , female breast carcinoma , progesterone-receptor positive breast cancer +1 National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 2
NCT01283035 Apr 2011 → Dec 2014 fallopian tube carcinoma , ovarian carcinoma , ovarian sarcoma , primary peritoneal carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01425879 Apr 2011 → May 2013 adult hepatocellular carcinoma , distal biliary tract carcinoma , gallbladder carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01251861 Mar 2011 → Jul 2018 prostate carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01307631 Mar 2011 → Sep 2015 endometrial adenosquamous carcinoma , endometrial clear cell adenocarcinoma , endometrial serous adenocarcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01333475 Mar 2011 → Nov 2013 colorectal neoplasm National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01277757 Mar 2011 → Aug 2014 breast carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01240941 Feb 2011 → Jun 2012 breast cancer Vanderbilt-Ingram Cancer Center
Withdrawn
No outcome recorded
Phase 2
NCT01294306 Feb 2011 → Aug 2015 adenosquamous lung carcinoma , lung adenocarcinoma , lung large cell carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01239342 Jan 2011 → Sep 2018 renal cell carcinoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 2
NCT01260701 Jan 2011 → May 2014 diffuse gastric adenocarcinoma , gastric intestinal type adenocarcinoma , gastroesophageal junction adenocarcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01258998 Dec 2010 → Jul 2014 B-cell adult acute lymphocytic leukemia , Hodgkins lymphoma , MALT lymphoma , T-cell adult acute lymphocytic leukemia +20 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01239355 Dec 2010 → Feb 2013 adult hepatocellular carcinoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 2
NCT01253447 Oct 2010 → Oct 2013 acute erythroid leukemia , acute megakaryoblastic leukemia in adult , acute myeloblastic leukemia with maturation , acute myeloblastic leukemia without maturation +8 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01186705 Aug 2010 → Aug 2011 colon carcinoma , rectal cancer Memorial Sloan Kettering Cancer Center
Terminated
No outcome recorded
Phase 2
NCT01169649 Jul 2010 → Feb 2014 neuroendocrine neoplasm , pancreatic neoplasm Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 2
NCT01042379 Mar 2010 → Dec 2030 expected HER2 positive breast carcinoma , angiosarcoma , female breast carcinoma , hormone receptor-positive breast cancer +1 QuantumLeap Healthcare Collaborative
Recruiting
No outcome recorded
Phase 2
NCT01249105 — malignant glioma Dana-Farber Cancer Institute
Withdrawn
No outcome recorded
Show 19 more trials